IP Library Granted Patent US 7,967,966
Granted Patent B2
US 7,967,966 · App. 11/090,234 · Granted Jun 28, 2011

System for pH-neutral stable electrophoresis gel

Assignee: Life Technologies Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,967,966
App. No.
11/090,234
Granted
Jun 28, 2011
Kind
B2
Abstract

A gel and buffer system for gel electrophoresis wherein separation occurs at neutral pH.

Claims (55)

1. A method for performing discontinuous gel electrophoresis, comprising:

a) selecting a discontinuous electrophoresis system from a pair of discontinuous electrophoresis systems, wherein the electrophoresis system is selected based on a molecular weight of a protein and the separation characteristics of the electrophoresis system, wherein each electrophoresis system of the pair of electrophoresis systems separates proteins of different molecular weights, and wherein the pair of electrophoresis systems comprises:

i) an electrophoresis separating gel comprising acrylamide and a gel buffer having a pH between 6 and 8, wherein the gel buffer comprises a primary organic amine or a substituted amine with a pK a near neutrality; and

ii) two separate running buffers each comprising a different zwitterionic compound, and

b) performing electrophoresis to resolve the protein in a sample using the selected electrophoresis system.

2. The method of claim 1 , wherein the running buffer in each electrophoresis system further comprises a primary organic amine or a substituted amine.

3. The method of claim 2 , wherein the primary organic amine or the substituted amine is different for each electrophoresis system of the pair of electrophoresis systems.

4. The method of claim 1 , wherein one of the different zwitterionic compounds is [N-(2-acetamido)]-2-aminoethanesulfonic acid (ACES).

5. The method of claim 1 , wherein one of the different zwitterionic compounds is 24N-morpholino]-2-hydroxypropanesulfonic acid (MOPSO).

6. The method of claim 1 , wherein one of the different zwitterionic compounds is 3-N-morpholinopropanesulfonic acid (MOPS).

7. The method of claim 1 , wherein one of the different zwitterionic compounds is 2-N-morpholinoethanesulfonic acid (MES).

8. The method of claim 1 , wherein one of the different zwitterionic compounds is piperazine-N,N′-2-ethanesulfonic acid (PIPES).

9. The method of claim 1 , wherein one of the different zwitterionic compounds is N-Tris-(hydroxymethyl)-2-ethanesulfonic acid (TES).

10. The method of claim 1 , wherein one of the different zwitterionic compounds is N,N-bis-(hydroxyethyl)-2-aminoethanesulfonic acid (BES).

11. The method of claim 1 , wherein one of the different zwitterionic compounds is N-2-hydroxyethyl-piperazine-N-2-ethanesulfonic acid (HEPES).

12. The method of claim 1 , wherein one of the different zwitterionic compounds is 3-(N-Tris-(hydroxymethyl) methylamino)-2-hydroxypropanesulfonic acid (TAPSO).

13. The method of claim 1 , wherein the two different zwitterionic compounds are 3-N-morpholinopropanesulfonic acid (MOPS) and 2-N-morpholinoethanesulfonic acid (MES).

14. The method of claim 1 , wherein the buffer gel electrophoresis system further comprises a reducing agent that is negatively charged at a neutral pH.

15. The method of claim 1 , wherein the electrophoresis separating gel is polymerized using 5% crosslinker.

16. The method of claim 1 , further comprising casting the electrophoresis separating gel with a gel buffer having a pH of between 6 and 8, prior to performing electrophoresis.

17. The method of claim 16 , wherein the electrophoresis separating gel is cast with a gel buffer having a pH of between 6.5 and 7.5.

18. The method of claim 16 , wherein the electrophoresis is performed at least 1 year after the gel has been cast.

19. The method of claim 16 , wherein the electrophoresis is performed between 2 months and 1 year after the gel has been cast.

20. The method of claim 16 , wherein the electrophoresis is performed 1 year after the gel has been cast.

21. The method of claim 16 , wherein the electrophoresis separating gel is cast in a disposable cassette.

22. The method of claim 21 , further comprising after the casting, and before the electrophoresis, storing the gel in a sealed package.

23. The method of claim 16 , wherein the electrophoresis separating gel is cast by an outside vendor.

24. The method of claim 1 , wherein the electrophoresis is carried out in an electrophoresis separating gel comprising between 3 and 25 (wt/vol)% acrylamide.

25. The method of claim 1 , wherein the electrophoresis is carried out in an electrophoresis separating gel comprising between 8 and 20 (wt/vol)% acrylamide and sodium dodecyl sulfate (SDS).

26. The method of claim 1 , wherein the pair of electrophoresis systems resolves proteins between 2 kDa and 200 kDa.

27. A pair of discontinuous electrophoresis systems comprising:

i) an electrophoresis separating gel comprising acrylamide and a gel buffer having a pH between 6 and 8, wherein the gel buffer comprises a primary organic amine or a substituted amine with a pKa in the range of 6 to 8; and

ii) two separate running buffers each comprising a different zwitterionic compound.

28. The pair of electrophoresis systems of claim 27 , wherein the running buffer in each electrophoresis system further comprises a primary organic amine or a substituted amine.

29. The pair of electrophoresis systems of claim 27 , wherein the primary organic amine or the substituted amine is different for each electrophoresis system of the pair of electrophoresis systems.

30. The pair of electrophoresis systems of claim 27 , wherein one of the different zwitterionic compounds is [N-(2-acetamido)]-2-aminoethanesulfonic acid (ACES).

31. The pair of electrophoresis systems of claim 27 , wherein one of the different zwitterionic compounds is 2-[N-morpholino]-2-hydroxypropanesulfonic acid (MOPSO).

32. The pair of electrophoresis systems of claim 27 , wherein one of the different zwitterionic compounds is 3-N-morpholinopropanesulfonic acid (MOPS).

33. The pair of electrophoresis systems of claim 27 , wherein one of the different zwitterionic compounds is 2-N-morpholinoethanesulfonic acid (MES).

34. The pair of electrophoresis systems of claim 27 , wherein one of the different zwitterionic compounds is piperazine-N,N′-2-ethanesulfonic acid (PIPES).

35. The pair of electrophoresis systems of claim 27 , wherein one of the different zwitterionic compounds is N-Tris-(hydroxymethyl)-2-ethanesulfonic acid (TES).

36. The pair of electrophoresis systems of claim 27 , wherein one of the different zwitterionic compounds is N,N-bis-(hydroxyethyl)-2-aminoethanesulfonic acid (BES).

37. The pair of electrophoresis systems of claim 27 , wherein one of the different zwitterionic compounds is N-2-hydroxyethyl-piperazine-N-2-ethanesulfonic acid (HEPES).

38. The pair of electrophoresis systems of claim 27 , wherein one of the different zwitterionic compounds is 3-(N-Tris-(hydroxymethyl) methylamino)-2-hydroxypropanesulfonic acid (TAPSO).

39. The pair of electrophoresis systems of claim 27 , wherein the two different zwitterionic compounds are 3-N-morpholinopropanesulfonic acid (MOPS) and 2-N-morpholinoethanesulfonic acid (MES).

40. The pair of electrophoresis systems of claim 27 , wherein the buffer gel electrophoresis system further comprises a reducing agent that is negatively charged at a neutral pH.

41. The pair of electrophoresis systems of claim 27 , wherein the electrophoresis separating gel has 5% by weight crosslinker.

42. The pair of electrophoresis systems of claim 41 , wherein the electrophoresis separating gel has a gel buffer having a pH of between 6.5 and 7.5.

43. The pair of electrophoresis systems of claim 41 , wherein the electrophoresis separating gel is at least 1 year old.

44. The pair of electrophoresis systems of claim 41 , wherein the electrophoresis separating gel is between 2 months and 1 year old.

45. The pair of electrophoresis systems of claim 41 , wherein the electrophoresis separating gel is 1 year old.

46. The pair of electrophoresis systems of claim 41 , wherein the electrophoresis separating gel is in a disposable cassette.

47. The pair of electrophoresis systems of claim 46 , wherein the disposable cassette is in a sealed package.

48. The pair of electrophoresis systems of claim 27 , wherein the electrophoresis separating gel comprises between 3 and 25 (wt/vol)% acrylamide.

49. The pair of electrophoresis systems of claim 27 , wherein the electrophoresis separating gel comprises between 8 and 20 (wt/vol)% acrylamide and sodium dodecyl sulfate (SDS).

Assignments (1)
CHANGE OF NAME Recorded Apr 13, 2010
From: LT NAME CORPORATION; INVITROGEN CORPORATION
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 024226/0938 →
Continuity (6)
Continuation 10369541 · Feb 21, 2003
Continuation 09728378 · Nov 28, 2000
Continuation 09228875 · Jan 11, 1999
Continuation 08730678 · Oct 11, 1996
Continuation In Part 08221939 · Mar 31, 1994
Related Publication 20050167269A1 · Aug 4, 2005